PHARMA AND TECH +++ +++ +

PHARMA AND TECH NPR: Eli Lilly Obesity Pill Foundayo Gets The FDA Green Light The Food and Drug Administration has approved the second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day and will compete with the pill form of Wegovy, made by Novo Nordisk, which was approved by the FDA in December. (Lupkin, 4/1) https://www.npr.org/2026/04/01/nx-s1-5760899/weight-loss-pill-foundayo?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_cECAGGXmQXXXcRfFR2SWkpeESrjvsveOe8Jeypa2cFOtuAX7DvD4lSi8ARPGXfKgHybGAqTSfXIeZwJgJcyiRHY9eBg&_hsmi=411919154&utm_content=411919154&utm_source=hs_email Fox News: Bariatric Surgeon Warns Against Microdosing GLP-1 Drugs For These Reasons The rise of GLP-1s (glucagon-like peptide-1 receptor agonists) has introduced new approaches to both weight loss and overall metabolic health. Some users have found that microdosing, or taking the drug in small amounts, achieves the best health outcomes, but some experts warn against it. (Stabile, 4/1) https://www.foxnews.com/health/should-you-microdose-ozempic-experts-split-risks-vs-benefits?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_T9LLrtSyFQsgvoYMQUHDKl1qaf0VAa1L-HGrInjocPi1g5nC4vxzKc7DS0WmthPBYEJZg6pxK04IBUfVcT7QI9tYoHA&_hsmi=411919154&utm_content=411919154&utm_source=hs_email Modern Healthcare: Oracle Layoffs: Where The Company's Health Division Stands Oracle began laying off thousands of employees Tuesday, including at Oracle Health, the unit it formed following its acquisition of electronic health records company Cerner Corp. The company is eliminating about 30,000 roles, which represents 18% of the company’s workforce, CNBC reported. Many of the affected employees took to social media and LinkedIn to announce they’d been laid off and were open to work. Oracle declined comment, as it has about past layoffs. (Famakinwa, 4/1) https://www.modernhealthcare.com/health-tech/mh-oracle-layoffs-ai-ehr-cerner/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9ombE0tFBmDnGd0H_ScDmBn7rPxUysEd9Bmw04PhXv0HCNk_qyESVaFHapwEv_Jl0PuDnWA8jHSSkRiI0HGqGsu-3vTg&_hsmi=411919154&utm_content=411919154&utm_source=hs_email Becker's Hospital Review: Meta Gets Into Health Wearables With AI Glasses Meta is entering the health wearables market with AI glasses designed to keep tabs on what you eat. The Meta AI glasses are now available for people with prescription lenses and come with hands-free food tracking as part of a software update. Via a voice prompt or photo, wearers can log what they eat, with the glasses extracting nutrition details and logging them into the Meta AI app. (Bruce, 4/1) https://www.beckershospitalreview.com/disruptors/meta-gets-into-health-wearables-with-ai-glasses/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9qBjuSeWSsaY5j0JWrlqV9-C8f7jcgxik6EV4uG3GdVbH7cic8rBo7QUR5fVzXRRFlTQPXyvKmfx26DSY6cYTFyyyLag&_hsmi=411919154&utm_content=411919154&utm_source=hs_email AP: Virtual Replicas Of Patients' Hearts Help Doctors Tackle Irregular Heartbeat Scientists created virtual replicas of patients’ diseased hearts so precise that blocking a dangerous irregular heartbeat in these digital “twins” showed doctors how to better treat the real thing. One of the first clinical trials of these custom models suggests it might improve care for ventricular tachycardia, a notoriously difficult-to-treat arrhythmia that is a major cause of sudden cardiac arrest, blamed for about 300,000 U.S. deaths a year. (Neergaard, 4/1) https://apnews.com/article/heart-disease-arrhythmia-ventricular-tachycardia-73086c0c3df8758380bef539940fa826?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_-gIxui5PDT5qh-XJRQWAYCfouT2ALAcR0XqLvlKjCjZD56IninGBl4X6edcYFEiAG3Z4TlqhyQe67h0zEPvzrvPDfvA&_hsmi=411919154&utm_content=411919154&utm_source=hs_email The Baltimore Sun: Howard Teens Develop Device To Help Those With Dementia Millions of people with dementia work hard to complete everyday tasks, from taking medication to locking the door. For families, keeping track of these small but essential routines can be exhausting, and missing a step can have serious consequences. Seeing a need through community and family, four juniors from Mount Hebron High School — Saanvi Kakarlapudi, 16; Ahana Roy, 16; Amitha Sabbani, 16; and Tanvi Anand, 17 — developed MindLink, a wearable device designed to act as an automatic to-do list. (Yelenik, 4/1) https://www.baltimoresun.com/2026/04/01/howard-teens-mount-hebron-mindlink-dementia/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8Az_g78P9ELYzwmrFMMhnBIvYFISweLT1lU3t7TWj1miGk94xaiT0iWP3aM089GdclSlcYK-kE20STnx-rdbwSPezuaw&_hsmi=411919154&utm_content=411919154&utm_source=hs_email The New York Times: Can Science Predict When A Study Won’t Hold Up? Scientists publish more than 10 million studies and other publications a year. Some of those findings will add to humanity’s storehouse of knowledge. But some will be wrong. To assess a study, scientists can replicate it to see if they get the same result. But seven years ago, a team of hundreds of scientists set out to find a faster way to judge new scientific literature. They built artificial intelligence systems to predict whether studies would hold up to scrutiny. (Zimmer, 4/1 https://www.nytimes.com/2026/04/01/science/ai-experiments-replication.html?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--SNW9on57FSQ3uv0KGdxTTI0g_iOWw3HeXcvMBdFXYhjPryVKH_Q2tBimtAmo5ZjN3c4UZjRNJ_dgDvPEJWBE4b77CiQ&_hsmi=411919154&utm_content=411919154&utm_source=hs_email